CC
Chardan Capital Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
51 |
51
Emergent Biosolutions
EBS
$404M
|
KN
Keay Nakae
| $7.58 | $55 |
626%
upside
| Buy | 2 years ago |
|
52 |
52
Core Scientific
CORZ
$4.16B
|
BD
Brian Dobson
| $13.62 | $0.2200 |
98%
downside
| Neutral | 2 years ago |
|
53 |
53
Regenxbio
RGNX
$490M
|
GL
Geulah Livshits
| $9.71 | $90 |
827%
upside
| Buy | 3 years ago |
|
54 |
54
Taysha Gene Therapies
TSHA
$917M
|
GA
Gbola Amusa
| $3.36 | $67.50 |
1,909%
upside
| Buy | 4 years ago |
|
55 |
55
Akero Therapeutics
AKRO
$3.58B
|
MM
Michael Morabito
| $44.72 | $81 |
81%
upside
| Buy | 4 years ago |
|
56 |
56
Solid Biosciences
SLDB
$428M
|
GA
Gbola Amusa
| $5.50 | $300 |
5,355%
upside
| Buy | 4 years ago |
|
57 |
57
uniQure
QURE
$985M
|
GA
Gbola Amusa
| $17.95 | $100 |
457%
upside
| Buy | 4 years ago |
|
58 |
58
Madrigal Pharmaceuticals
MDGL
$9.65B
|
MM
Michael Morabito
| $432.89 | $203 |
53%
downside
| Buy | 4 years ago |
|
59 |
59
Ocugen
OCGN
$322M
|
KN
Keay Nakae
| $1.03 | $13 |
1,162%
upside
| Neutral | 4 years ago |
|
60 |
60
Immunome
IMNM
$916M
|
GL
Geulah Livshits
| $10.52 | $18 |
71%
upside
| Buy | 4 years ago |
|
61 |
61
Iovance Biotherapeutics
IOVA
$901M
|
GA
Gbola Amusa
| $2.49 | $50 |
1,908%
upside
| Buy | 4 years ago |
|
62 |
62
89bio
ETNB
$1.32B
|
MM
Michael Morabito
| $8.87 | $95 |
971%
upside
| Buy | 5 years ago |
|
63 |
63
Viking Therapeutics
VKTX
$3.03B
|
MM
Michael Morabito
| $26.98 | $20 |
26%
downside
| Buy | 5 years ago |
|
64 |
64
Immunovant
IMVT
$2.99B
|
GA
Gbola Amusa
| $17.14 | $45 |
163%
upside
| Buy | 5 years ago |
|
65 |
65
Krystal Biotech
KRYS
$4.35B
|
GA
Gbola Amusa
| $150.27 | $115 |
23%
downside
| Buy | 5 years ago |
|
66 |
66
CRISPR Therapeutics
CRSP
$4.99B
|
GA
Gbola Amusa
| $54.86 | $100 |
82%
upside
| Buy | 5 years ago |
|
67 |
67
Moderna
MRNA
$9.78B
|
GA
Gbola Amusa
| $25.14 | $95 |
278%
upside
| Buy | 5 years ago |
|